Industries > Pharma > Brazilian Pharmaceutical Market Outlook 2017-2027

Brazilian Pharmaceutical Market Outlook 2017-2027

Originator, Generic, OTC, CNS, Cardiovascular, Gastrointestinal, Metabolic, Oncology, Infectious Diseases, Domestic Manufacturers and International Drug Companies

PUBLISHED: 18 August 2017
PAGES: 181
PRODUCT CODE: PHA0226

Clear
WOOCS 2.2.1

The Brazilian Pharmaceutical market was valued at $26.40bn in 2016. Visiongain forecasts this market to increase at a CAGR of 7.6% in the first half of the forecast period. Originator drugs held the largest market share in 2016, this trend however will change in the second half of the forecast period where we predicted that Generic drugs will take over the lead.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you find 181-page report you will receive 107 charts – all unavailable elsewhere.

The 181-page report provides clear detailed insight into the Brazilian Pharmaceutical market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Brazilian Pharmaceutical Market forecasts from 2017-2027

• Brazilian Pharmaceutical Market forecasts from 2017-2027, by segment:
• Originator Drugs
• Generic Drugs
• OTC

Brazilian Pharmaceutical Market forecasts from 2017-2027, by therapeutic area:
• CNS
• Cardiovascular
• Gastrointestinal/Metabolic
• Oncology
• Infectious Disease

Brazilian Pharmaceutical Market Outlook 2017-2027

• Leading Domestic Companies in the Brazilian Pharmaceutical Market:
• EMS
• Hypermarcas
• Medley
• Eurofarma
• Aché
• Cristalia
• Teuto
• Libbs
• Biolab
• União Química

• Leading Multinational Companies in the Brazilian Pharmaceutical Market:
• Novartis
• Sanofi
• Roche
• Merck & Co.
• Pfizer
• Takeda
• Bayer
• GlaxoSmithKline
• Boehringer Ingelheim
• Astra Zeneca

SWOT and STEP Analysis of the Brazilian Pharmaceutical market

• This report also discusses:
• The Brazilian healthcare environment, covering important institutional bodies and agencies, surveying the regulatory system, analyzing the balance between public and private healthcare provision and looking at the wholesale and distribution landscape
Regional variations within Brazil, with profiles of each region and an analysis of their healthcare challenges and opportunities
Brazilian Biologics Market, which includes qualitative and quantitative analysis.

Visiongain’s study is intended for anyone requiring commercial analyses for the Brazilian Pharmaceutical market and the leading companies competing in that country. You find data, trends and predictions.

Buy our report today Brazilian Pharmaceutical Market Outlook 2017-2027: Originator, Generic, OTC, CNS, Cardiovascular, Gastrointestinal, Metabolic, Oncology, Infectious Diseases, Domestic Manufacturers and International Drug Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Brazilian Pharmaceutical Market Outlook 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Brazilian Pharmaceutical Market Outlook 2017-2027


Latest Pharma news

Visiongain Publishes Ophthalmic Devices Market Report 2022-2032

The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.

19 April 2022

READ

Visiongain Publishes Vaccine Contract Manufacturing Market Report 2022-2032

The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet

13 April 2022

READ

Visiongain Publishes Pharmaceutical Contract Manufacturing Market Report 2022-2032

The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.

13 April 2022

READ

Visiongain Publishes Vaccine Sales Market Report 2022-2032

Rising epidemic potential, a growing emphasis on therapeutic vaccines, and new markets are projected to provide considerable growth prospects for vaccine providers.

30 March 2022

READ

Categories